Psychiatric treatment considerations with direct acting antivirals in hepatitis C

BACKGROUND: Despite recent advances in hepatitis C (HCV) treatment, specifically the addition of direct acting antivirals (DAAs), pegylated interferon-alpha remains the backbone of HCV therapy. Therefore, the impact of DAAs on the management of co-morbid psychiatric illness and neuropsychiatric sequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Sockalingam, Sanjeev, Tseng, Alice, Giguere, Pierre, Wong, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658966/
https://www.ncbi.nlm.nih.gov/pubmed/23672254
http://dx.doi.org/10.1186/1471-230X-13-86

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658966/
https://www.ncbi.nlm.nih.gov/pubmed/23672254
http://dx.doi.org/10.1186/1471-230X-13-86

Ejemplares similares